General Information of This Antibody-drug Conjugate (ID: DRG0HVNZU)
ADC Name
SHR-4394
Synonyms
SHR-4394
   Click to Show/Hide
Organization
Jiangsu Hengrui Pharmaceuticals (Originator)
Drug Status
Phase 1/2
Antibody Name
Anti-PSMA mAb
 Antibody Info 
Antigen Name
Glutamate carboxypeptidase 2 (FOLH1)
 Antigen Info 
Payload Name
SHR9265
 Payload Info 
Payload Target
DNA topoisomerase 1 (TOP1)
 Target Info 
Linker Name
A cleavable linker
 Linker Info 
Conjugate Type
Undisclosed
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
Disease Name Phase 1 Phase 2 Phase 3 Approved
Prostate cancer
1 Trials
Clinical trial identifier
NCT06783829; CTR20250145; ChiCTR2500096042